- Report
- November 2023
- 182 Pages
Global
From €3363EUR$3,825USD£2,898GBP
€3956EUR$4,500USD£3,409GBP
- Report
- September 2023
- 200 Pages
Global
From €3164EUR$3,599USD£2,727GBP
- Report
- April 2023
- 160 Pages
Global
From €4351EUR$4,949USD£3,749GBP
- Report
- April 2023
- 160 Pages
Global
From €4351EUR$4,949USD£3,749GBP
- Report
- October 2023
- 133 Pages
Global
From €2989EUR$3,400USD£2,576GBP
€3737EUR$4,250USD£3,220GBP
- Report
- May 2024
- 200 Pages
Global
From €3649EUR$4,150USD£3,144GBP
- Report
- October 2023
- 145 Pages
Global
From €2769EUR$3,150USD£2,386GBP
- Report
- November 2023
- 148 Pages
Global
From €3130EUR$3,560USD£2,697GBP
€3912EUR$4,450USD£3,371GBP
- Report
- February 2024
- 180 Pages
Global
From €4369EUR$4,969USD£3,764GBP
- Report
- March 2024
- 185 Pages
Asia Pacific
€4392EUR$4,995USD£3,784GBP
- Report
- February 2024
- 380 Pages
Global
€4392EUR$4,995USD£3,784GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,264USD£3,121GBP
- Book
- December 2024
- 1440 Pages
- Book
- May 2024
- 368 Pages
- Book
- November 2021
North America

The Autoimmune Disorder market is a subset of the Allergy and Immunology field. It focuses on the diagnosis and treatment of diseases caused by an overactive immune system. These diseases can affect any organ or tissue in the body, and can range from mild to life-threatening. Common autoimmune disorders include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment typically involves medications to suppress the immune system, as well as lifestyle changes to reduce inflammation.
The Autoimmune Disorder market is highly competitive, with many companies offering treatments and therapies. These include pharmaceutical companies such as AbbVie, Amgen, and Biogen, as well as biotechnology companies such as Gilead Sciences and Celgene. Additionally, there are a number of smaller companies that specialize in specific autoimmune disorders, such as Mylan and Alexion Pharmaceuticals. Show Less Read more